

( (S (NP-SBJ (NP Ciba-Geigy AG)
             ,
             (NP the big Swiss chemicals company)
             ,)
     (VP said
         (SBAR that
               (S (NP-SBJ-1 it)
                  (VP agreed
                      (PP-LOC in
			      (NP (NP a letter)
				  (PP of
				      (NP intent))))
                      (PP-CLR with
			      (NP Corning Inc.))
                      (S (NP-SBJ *-1)
                         (VP to
                             (VP acquire
                                 (NP (NP (NP Corning 's)
					 (ADJP 50 %) 
					 share)
                                     (PP of
                                         (NP (NP Ciba Corning Diagnostics Corp.)
                                             ,
                                             (VP based
                                                 (NP *)
                                                 (PP-LOC-CLR in
							     (NP (NP Medfield)
								 ,
								 (NP Mass))))))))))))))
     .))
( (S (S-TPC-1 (NP-SBJ (NP Ciba Corning)
		      ,
		      (SBAR (WHNP-51 which)
			    (S (NP-SBJ *T*-51)
			       (VP had
				   (VP been
				       (NP-PRD (NP a 50-50 venture)
					       (PP between
						   (NP (NP Basel-based Ciba-Geigy)
						       and
						       (NP Corning))))))))
		      ,)
	      (VP has
		  (NP (NP annual sales)
		      (PP of
			  (NP (QP about
				  $ 300 million) *U*)))))
     ,
     (NP-SBJ the announcement)
     (VP said
	 (SBAR 0
	       (S *T*-1)))
     .))
( (S (NP-SBJ-1 (NP Terms)
	       (PP of
		   (NP the transaction)))
     (VP were n't
         (VP disclosed
	     (NP *-1)))
     .))
( (S (NP-SBJ Ciba Corning)
     (VP makes
         (NP (NP (NP clinical diagnostics systems)
		 and
		 (NP related products))
	     (PP for
		 (NP the medical-care industry))))
     .))
( (S (NP-SBJ The announcement)
     (VP said
         (SBAR 0
               (S (NP-SBJ-1 the acquisition)
                  (VP should
		      (VP be
			  (VP completed
			      (NP *-1)
			      (PP-TMP by
				      (NP December))
			      (SBAR-TMP after
					(S (S (NP-SBJ-2 a definitive agreement)
					      (VP is
						  (VP completed
						      (NP *-2))))
					   and
					   (S (NP-SBJ-3 regulatory approval)
					      (VP is
						  (VP received
						      (NP *-3))))))))))))
     .))
( (S (NP-SBJ-1 Ciba-Geigy)
     (VP intends
         (S (NP-SBJ-2 *-1)
            (VP to
                (VP develop
                    (NP the Ciba Corning unit)
                    (PP-CLR into
			    (NP a `` substantial business))
		    ,
		    ''
		    (S-ADV (NP-SBJ *-2)
			   (VP making
			       (S (NP-SBJ the unit)
				  (NP-PRD (NP an `` integral part '')
					  (PP of
					      (NP (NP Ciba-Geigy 's)
						  `` 
						  comprehensive 
						  disease management 
						  concept))))))))))
     .))
